Authorised Therapeutic use (Phase IV) Prevention of female infertility.

RAndom sTArT Ovarian stimUlatIon (RSOS) in eLective oocyte cryopreservation cycLEs (RATATOUILLE): a single-center, non-inferiority, randomised controlled trial

EU CTIS ID: 2023-509919-89-00

What this study is testing

The aim of the current randomized controlled trial is to compare the efficacy of Random Start Ovarian Stimulation to conventional early follicular phase stimulation in Elective Oocyte Cryopreservation cycles.

Therapeutic use (Phase IV)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

 Age from ≥ 25 to ≤ 39 years
 Body mass Index (BMI) ≥18 to < 30 kg/m2
 Signed informed consent
 Regular menstrual cycle length i.e. 24-35 days
 Patients who are not taking hormonal contraception or who stopped hormonal contraception at least 2 months ago
 Normally accessible ovaries/ ovary

You likely can't join if

 Patients currently taking hormonal contraception (including intrauterine devices)
 Contraindications to the use of gonadotropins
 Endometriosis grade 3-4
 Patients with Anti-müllerian hormone (AMH) <0.5 ng/mL (Revelli et al., JARG 2016) or AMH >3.2 ng/mL (Roche Diagnostics PCOM)
 Any untreated endocrine abnormality

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.

Explore other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH)Heart failure Coronary artery disease

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.